Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Phase IIIb/IV, multicentre, open-label, single-arm study to investigate the efficacy and safety of faricimab (RO6867461) in patients with polypoidal choroidal vasculopathy

    • Eye Disorder
    • Polypoidal Choroidal Vasculopathy (PCV)